促进鼻窦癌研究的EUSICA/COST IMMUNO模型工作坊：会议报告。
EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.
发表日期：2023 Aug 11
作者：
Mario A Hermsen, Matt Lechner, Leticia Oliveira Ferrer, Annalisa Trama, Patrick René Gerhard Eriksen, Eva Martinez-Balibrea, Christian von Buchwald
来源：
ORAL ONCOLOGY
摘要：
鼻窦癌是一种临床和组织学上异质性较大、临床转归一般较差的罕见肿瘤群。由于其低发病率，限制了临床治疗和转化研究的进展，需要医生和研究人员之间的多中心和多国际合作。本报告描述了由欧洲鼻窦癌研究网络（EUSICA）和COST行动“免疫模型”组织的为期两天的会议的进程，促进这种合作，重点关注前临床肿瘤和免疫模型、外科和放射治疗、用于基因特征和分子肿瘤分类的核心设施以及癌症登记。版权所有 © 2023. Elsevier Ltd.出版。
Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.Copyright © 2023. Published by Elsevier Ltd.